Against the backdrop of the continuous growth of cross-border pharmaceutical trade, the timeliness, compliance, and safety of drug transportation have become core concerns for healthcare institutions and pharmaceutical distributors. As a platform focused on international pharmaceutical supply chain services, Dengyue Pharma provides stable and efficient cross-border drug logistics solutions through its well-established China pharmaceutical freight service system and standardized customs declaration and clearance processes.

1. China Pharmaceutical Freight Services: Balancing Efficiency and Safety

Pharmaceutical products are highly regulated and must meet multiple requirements during transportation, including temperature control, specialized packaging, shock protection, and real-time tracking. By integrating air transport, land transit, and professional cold-chain delivery resources, Dengyue Pharma offers differentiated freight solutions tailored to various types of medicines.

Key transportation advantages include:

● Multi-route transport solutions: Flexible matching of shipping methods based on drug category, destination, and delivery timelines

● Cold-chain support: Suitable for biologics, vaccines, and certain specialty medicines to ensure full-process temperature control

● Real-time logistics tracking: Enhances shipment transparency and supply chain visibility

● Freight cost optimization: Reduces overall logistics costs through large-scale procurement of transport resources

This safety- and efficiency-oriented transportation system helps maintain pharmaceutical quality and minimizes clinical risks caused by delivery delays.

2. Compliant Customs Declaration Operations: Reducing Cross-Border Risks

Cross-border circulation of pharmaceuticals involves strict legal regulations and documentation review. Dengyue Pharma has established standardized operating procedures for pharmaceutical export customs declaration in China, ensuring that all processes—from document preparation to submission—strictly comply with relevant regulatory requirements.

Key customs declaration services include:

● Review and preparation of export documentation: Such as drug registration certificates, invoices, packing lists, and shipping documents

● HS code classification and compliant declaration: Ensures accurate product classification and reduces inspection risks

● Regulatory policy monitoring: Timely response to changing pharmaceutical regulations across countries and regions

● Coordination with port regulatory authorities: Improves declaration efficiency and customs clearance success rates

With professional operational support, risks of delays or shipment returns caused by incomplete documentation or declaration errors can be effectively reduced.

3. Professional Customs Clearance Services: Improving Delivery Efficiency

In destination countries or regions, pharmaceutical customs clearance is also a critical factor affecting delivery timelines. Leveraging its international cooperation network, Dengyue Pharma assists clients with import permit coordination, tax and duty assessment, and local distribution arrangements.

Advantages of its customs clearance services include:

● Local clearance partnerships: Familiarity with regional pharmaceutical regulatory systems

● Pre-declaration mechanisms: Shortens port dwell time for shipments

● Tax and compliance consulting support: Helps clients optimize import cost planning

● Exception handling capabilities: Addresses inspections, supplementary documentation requirements, or policy changes

Through systematic clearance management, the stability and predictability of pharmaceutical delivery can be significantly improved.

4. Building an Efficient and Compliant Cross-Border Pharmaceutical Supply Chain

Overall, Dengyue Pharma has developed a comprehensive pharmaceutical supply chain service system covering both logistics and compliance through freight service optimization, standardized customs declaration operations, and professional clearance support. This model not only helps reduce cross-border trade risks but also ensures that healthcare institutions can obtain innovative medicines in a timely manner.

As global demand for pharmaceutical circulation continues to grow, medical service providers with strong logistics integration capabilities and compliant operational experience will play an increasingly important role in improving drug accessibility and promoting international healthcare collaboration.